X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2018 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare TTK HEALTHCARE with GSK Pharma - Equitymaster
  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

TTK HEALTHCARE vs GSK PHARMA - Comparison Results

GSK PHARMA 
   Change

GSK Pharma is one of the leading MNC pharma companies in the Indian market. It is a 50.7% subsidiary of GlaxoSmithKline Plc, one of the world's largest pharma companies. GSK Pharma's product portfolio boasts of some of the leading brands like Augment... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    TTK HEALTHCARE GSK PHARMA TTK HEALTHCARE/
GSK PHARMA
 
P/E (TTM) x 50.3 63.6 79.2% View Chart
P/BV x 9.3 10.2 90.7% View Chart
Dividend Yield % 0.3 1.2 25.3%  

Financials

 TTK HEALTHCARE   GSK PHARMA
EQUITY SHARE DATA
    TTK HEALTHCARE
Mar-14
GSK PHARMA
Mar-17
TTK HEALTHCARE/
GSK PHARMA
5-Yr Chart
Click to enlarge
High Rs6633,838 17.3%   
Low Rs3992,637 15.1%   
Sales per share (Unadj.) Rs535.6354.2 151.2%  
Earnings per share (Unadj.) Rs15.939.8 40.1%  
Cash flow per share (Unadj.) Rs20.042.9 46.7%  
Dividends per share (Unadj.) Rs4.0030.00 13.3%  
Dividend yield (eoy) %0.80.9 81.3%  
Book value per share (Unadj.) Rs137.6236.9 58.1%  
Shares outstanding (eoy) m7.7784.70 9.2%   
Bonus/Rights/Conversions ---  
Price / Sales ratio x1.09.1 10.8%   
Avg P/E ratio x33.381.4 40.9%  
P/CF ratio (eoy) x26.575.5 35.1%  
Price / Book Value ratio x3.913.7 28.2%  
Dividend payout %25.175.4 33.2%   
Avg Mkt Cap Rs m4,127274,216 1.5%   
No. of employees `0001.74.7 36.4%   
Total wages/salary Rs m6074,830 12.6%   
Avg. sales/employee Rs Th2,436.76,387.0 38.1%   
Avg. wages/employee Rs Th355.21,028.3 34.5%   
Avg. net profit/employee Rs Th72.5717.1 10.1%   
INCOME DATA
Net Sales Rs m4,16230,000 13.9%  
Other income Rs m61728 8.4%   
Total revenues Rs m4,22330,728 13.7%   
Gross profit Rs m1974,190 4.7%  
Depreciation Rs m32263 12.1%   
Interest Rs m300-   
Profit before tax Rs m1974,655 4.2%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m0457 0.0%   
Tax Rs m731,744 4.2%   
Profit after tax Rs m1243,368 3.7%  
Gross profit margin %4.714.0 33.9%  
Effective tax rate %37.037.5 98.8%   
Net profit margin %3.011.2 26.5%  
BALANCE SHEET DATA
Current assets Rs m1,62916,742 9.7%   
Current liabilities Rs m1,0587,202 14.7%   
Net working cap to sales %13.731.8 43.1%  
Current ratio x1.52.3 66.2%  
Inventory Days Days3052 57.5%  
Debtors Days Days3421 161.6%  
Net fixed assets Rs m5568,635 6.4%   
Share capital Rs m78847 9.2%   
"Free" reserves Rs m87819,222 4.6%   
Net worth Rs m1,06920,069 5.3%   
Long term debt Rs m15910 1,587.0%   
Total assets Rs m2,39930,038 8.0%  
Interest coverage x7.6NM-  
Debt to equity ratio x0.10 29,784.7%  
Sales to assets ratio x1.71.0 173.7%   
Return on assets %6.411.2 57.2%  
Return on equity %11.616.8 69.0%  
Return on capital %18.525.5 72.5%  
Exports to sales %0.80-   
Imports to sales %1.40-   
Exports (fob) Rs m33NA-   
Imports (cif) Rs m58NA-   
Fx inflow Rs m33528 6.2%   
Fx outflow Rs m637,193 0.9%   
Net fx Rs m-30-6,665 0.5%   
CASH FLOW
From Operations Rs m1272,360 5.4%  
From Investments Rs m-1463,008 -4.9%  
From Financial Activity Rs m22-5,108 -0.4%  
Net Cashflow Rs m3260 1.0%  

Share Holding

Indian Promoters % 65.4 0.0 -  
Foreign collaborators % 0.0 50.7 -  
Indian inst/Mut Fund % 3.7 10.2 36.3%  
FIIs % 5.2 23.8 21.8%  
ADR/GDR % 0.0 0.0 -  
Free float % 25.8 15.4 167.5%  
Shareholders   12,723 102,036 12.5%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare TTK HEALTHCARE With:   ALKEM LABORATORIES  PLETHICO PHARMA  WOCKHARDT LTD.  TORRENT PHARMA  FRESENIUS KABI ONCO.  

Compare TTK HEALTHCARE With:   ADCOCK INGRAM (S. Africa)  MYLAN (US)  ACTAVIS (US)  TEVA PHARMA (Israel)  



Today's Market

Of PNB Fraud, Rising Troubles at PSBs, and Top Cues in Focus Today(Pre-Open)

Share markets in India closed on a negative note yesterday. At the closing bell yesterday, the BSE Sensex stood lower by 236 points and the NSE Nifty closed down by 74 points.

Related Views on News

Aster DM Healthcare (IPO)

Feb 10, 2018

Should you subscribe to the IPO of Aster DM Healthcare Ltd?

Dr Reddy's: Milestone Payment Drives Sales (Quarterly Results Update - Detailed)

Feb 9, 2018

US business was hit by pricing pressure although there was growth sequentially led by new product launches.

Lupin: US market Declines Due to Higher Base Effect of FY17 (Quarterly Results Update - Detailed)

Feb 9, 2018

Price erosion in generic US drugs continues but seems to be bottoming out.

Biocon: US Pricing Pressure Takes Toll (Quarterly Results Update - Detailed)

Feb 2, 2018

Pricing pressure in the US and costs of the Malaysian facility hit Biocon's profits in the third quarter.

Shalby Ltd. (IPO)

Dec 2, 2017

Should you subscribe to the IPO of Shalby Ltd?

More Views on News

Most Popular

Follow India's Super Investors to Make Big Money in the Market Crash(The 5 Minute Wrapup)

Feb 8, 2018

Has the sell-off in the markets left India's super investors unduly worried?

The Era of Easy Money is Coming to an End. What Happens Now?(Vivek Kaul's Diary)

Feb 9, 2018

The easy money policy of the Federal Reserve of the United States, which drove up stock markets all over the world, is ending, with the Federal Reserve looking to shrink its balance sheet.

The Markets Want Your Money. Don't Give It to Them.(Smart Contrarian)

Feb 9, 2018

MFs are having a gala time taking money from over-eager investors and funneling it into equities. Smart investors, though, know better than to do that.

The Big Gamble(The Honest Truth)

Feb 15, 2018

Once you accept the fact that elections are round the corner and that this budget is geared to reach a 40% target, everything makes sense.

Rising Dominance of Mutual Funds(Chart Of The Day)

Feb 8, 2018

Domestic money flow into Indian equities surpassed foreign fund flows in the recent years. But will it continue in volatile market?

More

Small Investments
BIG Returns

Zero To Millions Guide 2018
Get our special report, Zero To Millions
(2018 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

TTK HEALTHCARE SHARE PRICE


Feb 19, 2018 (Close)

TRACK TTK HEALTHCARE

  • Track your investment in TTK HEALTHCARE with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON TTK HEALTHCARE

TTK HEALTHCARE - SHASUN PHARMA COMPARISON

COMPARE TTK HEALTHCARE WITH

MARKET STATS